COVID Testing & Treatment

COVID Testing


Mobile Care offers workplace COVID testing in the Denver metro area. We know the team is ready to get back to work and preventing infections is a top priority. Ready to send the team travelling, we have you covered with testing that meets international requirements. We offer rapid COVID tests and PCR tests, both look for active infection. Mobile Care uses a nasal antigen test or a nasopharyngeal PCR test. The best part, we come to your team! Whether you are visiting or live in the mile-high city, we can test groups of 6 or more, just let us know when and where.



Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus like the virus that causes COVID-19. That’s why mAb treatment may help patients who are at high risk for severe symptoms or hospitalization. The Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID-19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19. Find out if you qualify for treatment below or call us 720-541-9570

Supplied by BMI Calculator USA



Monoclonal antibodies, or mAbs, help stop the replication of the COVID-19 virus. Currently, all mAbs are under a EUA and not FDA approved. However, mAbs are one of the few treatment options that have been shown to work, reduce symptoms, and prevent hospitalization and or ICU admission. The infusion requires the placement of an IV in your arm. When the infusion is complete (40min) we monitor you for an hour. The whole process is 2 hours, all from the comfort of your home. We work with you to submit all required documentation for full reimbursement. Mobile Care also accepts HSA for payment. Find out if you qualify for free treatment through the health department here.

Monoclonal Antibodies


Eligibility for post-exposure prophylaxis monoclonal antibody therapy. Bamlanivimab/etesevimab and REGEN-COV are authorized to prevent COVID-19 after exposure in adults and pediatric patients who: Are at high risk of developing severe illness; AND Are not fully vaccinated OR are not expected to adequately respond to a COVID-19 vaccination (for example, people with immunocompromising conditions and those taking immunosuppressive medications); AND Have been exposed to an individual infected with COVID-19 consistent with close contact criteria per the CDC (someone who has been within six feet of an infected person for a total of 15 minutes or more over a 24-hour period) OR are at high risk of exposure to an individual infected with COVID-19 because of occurrence of COVID-19 infection in other individuals in the same institutional setting.

Methylene Blue


Methylene blue (MB) is a dye that was first developed to stain and inactivate certain microbes. In 1891 it was used for malaria treatment, and since has been used for multiple different diseases. Over the past 2 years MB has been studied in COVID patients. It decrease the production of reactionary oxygen species (ROS). MB inhibits the binding of the viral spike (S) protein (glycoprotein) with angiotensin converting enzyme 2 (ACE2) receptors initiates SARS-CoV infection of host cells. This reduces the replication of the virus. In COVID long haulers (LHC) MB reduces cyclic inflammatory response and increases intracellular energy.